论文部分内容阅读
目的:观察解表散寒法对肝癌介入术后患者恶心/呕吐、发热、头痛等并发症的治疗效果。方法:对20例肝癌介入治疗术后患者使用解表散寒法治疗,分别在5天和2周内对症状完全缓解患者的病例数进行统计分析。结果:20例患者中,5天内恶心、发热、头痛等症状完全缓解患者中,解表散寒法有效率分别为80%、86%、78%,而对症处理组分别是25%、25%、0,治疗组明显优于对照组(P均小于0.01);2周内恶心、发热、头痛等症状缓解,解表散寒法有效率分别为93%、100%、100%,而对症处理组分别是75%、58%、67%,治疗组对发热的疗效明显优于对照组(P<0.05)而对恶心/呕吐和头痛的缓解无明显差异。结论:以祛风散寒法治疗肝癌介入术后恶心/呕吐、发热、头痛等常见并发症,可以明显缩短病程,临床疗效满意,值得进一步推广应用。
OBJECTIVE: To observe the therapeutic effect of relieving nausea / vomiting, fever, headache and other complications in patients with liver cancer after interventional treatment of relieving cold and relieving cold. Methods: Twenty patients with post-interventional hepatocellular carcinoma (HCC) were treated with relieving symptoms and dispelling cold, and the number of patients with complete symptomatic relief was statistically analyzed within 5 days and 2 weeks respectively. Results: Among the 20 patients, the effective rates of relieving discomfort and relieving cold were 80%, 86% and 78% respectively in patients with complete remission of nausea, fever and headache within 5 days, while those in symptomatic treatment group were 25% and 25% , 0, the treatment group was significantly better than the control group (P less than 0.01); nausea, fever, headache and other symptoms ease within 2 weeks, relieve and relieve cold were 93%, 100%, 100% Group were 75%, 58%, 67%, the treatment group was significantly better than the control group fever (P <0.05) and nausea / vomiting and headache relief no significant difference. Conclusion: The common complications of nausea / vomiting, fever and headache after interventional treatment of liver cancer with expelling wind and dispersing cold can obviously shorten the course of disease, and the clinical curative effect is satisfactory, so it is worth to be further popularized and applied.